Learn from the Sanger experts how you can get the most of your DNA Sequencing
Preserving the integrity of inverted terminal repeat (ITR) sequences in adeno-associated virus (AAV) plasmids is important to produce recombinant AAV (rAAV) vectors. Azenta’s proprietary AAV plasmid preparation service delivers superior quality for midi to giga-scale AAV vectors, while maintaining the integrity of ITR regions. Our new process includes pre- and post-preparation quality controlled (QC) steps that leverage Azenta's AAV-ITR Sanger sequencing capabilities for full sequence verification and ensures delivery of intact ITR clones for your research.
Download NowAzenta has developed a high-quality, direct Sanger sequencing method that reads through both intact and commonly mutated inverted terminal repeat (ITR) regions of adeno-associated virus (AAV). This method is an effective tool for assessing the integrity of ITRs in AAV plasmids.
Download NowThis tech note describes how Azenta scientists used optimized single-cell workflows, including dead cell removal, to overcome low viability and generate high-quality sequencing data on the 10x Genomics® Chromium™ platform.
Download NowUsing only ~50 tumor cells as input, Azenta generated high quality transcriptomic data that enabled researchers to publish in a top journal.
Download NowDiscover the value of scRNA-seq in identifying rare cells, characterizing their transcriptomes, and discovering potential biomarkers in this Azenta-exclusive study.
Download NowDiscover the powerful capability of genoTYPER-NEXT in this illuminating case study that discusses this new technology and how it's helping researchers analyze NGS DATA.
Download NowDownload this case study now to learn why researchers at a large bio-pharmaceutical company chose Azenta’s Trimer-Controlled Library solution to obtain a highly accurate mutant library.
Download NowThis guide will help you choose protocols for making competent cells and appropriate strains for your experiment.
Download NowThis study proves the feasibility of multiplexing and highlights the key advantages of the PacBio Sequel platform as compared to its predecessor, the RSII.
Download NowThis case study looks at how Azenta utilized the PacBio® Sequel™ long-read technology to help a customer improve detection of structural variants within glioblastoma samples.
Download Now